$KNSA Kiniksa Pharmaceuticals, Ltd. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kiniksa Pharmaceuticals, Ltd..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Kiniksa Pharmaceuticals, Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in Kiniksa Pharmaceuticals, Ltd. for free.

CIK Number: 0001730430
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KNSA
Company Address: CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM11
Phone number: 808-451-3453

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.

Kiniksa Pharmaceuticals, Ltd. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 28 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA0.003,96203,962
Apr 28 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA16.9023,725400,95323,725
Mar 23 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA0.002,15802,158
Mar 23 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA0.003,01903,019
Mar 23 2021KNSAKiniksa Pharmaceut ...Paolini John F.SVP & Chief Medical ...Option ExerciseA0.003,67103,671
Mar 23 2021KNSAKiniksa Pharmaceut ...Paolini John F.SVP & Chief Medical ...Option ExerciseA0.005,67605,676
Mar 23 2021KNSAKiniksa Pharmaceut ...Megna Michael RChief Accounting Of ...Option ExerciseA0.002,16302,163
Mar 23 2021KNSAKiniksa Pharmaceut ...Megna Michael RChief Accounting Of ...Option ExerciseA0.003,23103,231
Mar 23 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA0.0012,002012,002
Mar 23 2021KNSAKiniksa Pharmaceut ...Patel Sanj KChairman & CEOOption ExerciseA0.0018,555018,555
Mar 23 2021KNSAKiniksa Pharmaceut ...Beetham Thomas W.EVP & Chief Legal O ...Option ExerciseA0.004,28704,287
Mar 23 2021KNSAKiniksa Pharmaceut ...Beetham Thomas W.EVP & Chief Legal O ...Option ExerciseA0.005,85505,855
Mar 18 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA0.003,48803,488
Mar 18 2021KNSAKiniksa Pharmaceut ...Ragosa MarkCFOOption ExerciseA22.8920,925478,97320,925
Mar 18 2021KNSAKiniksa Pharmaceut ...Megna Michael RChief Accounting Of ...Option ExerciseA0.003,09803,098

View all Kiniksa Pharmaceuticals, Ltd. insider transactions.